Are Semaglutide and Tirzepatide in the same research category?

Yes. Both are catalogued under metabolic & incretin research, and they share research areas including GLP-1 receptor binding and signalling assays and Comparative incretin peptide analytics. Shared categorisation is not a statement that they behave the same way or that one can replace the other.

Do Semaglutide and Tirzepatide need the same storage conditions?

Both are specified at 2–8 °C (lyophilized, sealed) in sealed lyophilized or supplied form, so a single storage location covers both. Always follow the condition printed on the vial label and the published COA for the lot you received.

Which does VaultLabs stock, Semaglutide or Tirzepatide?

Both. Semaglutide is listed as 1 catalog sku and Tirzepatide as 1 catalog sku, each dispatched from the UAE with lot details you can check through batch verification before ordering.

Can Semaglutide be substituted for Tirzepatide in an experiment?

No substitution guidance is provided. Material selection belongs to the validated protocol of the receiving laboratory, which should be based on published specifications and the COA for the specific lot. VaultLabs supplies reference materials and documentation only.

Does this comparison include human outcome data?

No. It describes catalog specifications, supplied form, storage requirements and published research categories. VaultLabs does not provide medical, dosing or human-use information for any compound.

Compound comparison

Semaglutide vs Tirzepatide

Semaglutide and Tirzepatide are both catalogued under metabolic & incretin research, which is why laboratories often weigh one against the other. This page compares their published specifications, supplied form, storage requirements and VaultLabs catalog status side by side. Specifications and research context only — no dosing, protocol or human-use guidance.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Attribute	Semaglutide	Tirzepatide
Category	Metabolic & incretin research	Metabolic & incretin research
Compound type	Incretin GLP-1 agonist peptide	Incretin dual-agonist peptide
CAS number (literature)	910463-68-2 (literature)	2023788-19-2 (literature)
Supplied form	Lyophilized powder	Lyophilized powder
Appearance	White to off-white lyophilized material	White to off-white lyophilized material
Storage temperature	2–8 °C (lyophilized, sealed)	2–8 °C (lyophilized, sealed)
Primary research area	GLP-1 receptor binding and signalling assays	Dual incretin receptor pharmacology
Also referenced as	GLP-1 receptor agonist peptide, NN9535	LY3298176, dual GIP/GLP-1 agonist peptide
Batch verification	Lot lookup available	Lot lookup available
VaultLabs catalog	1 catalog SKU	1 catalog SKU

Shared research areas

GLP-1 receptor binding and signalling assays
Comparative incretin peptide analytics

Key differences

Material type differs — Semaglutide is supplied as incretin glp-1 agonist peptide, Tirzepatide as incretin dual-agonist peptide.
Primary literature focus — GLP-1 receptor binding and signalling assays vs Dual incretin receptor pharmacology.

Storage comparison

Both are stored at 2–8 °C (lyophilized, sealed), so they can share the same cold-chain and inventory conditions. Semaglutide: 2–8 °C sealed lyophilized storage. Tirzepatide: 2–8 °C sealed; temperature-aware UAE dispatch recommended.

FAQ

Catalog availability

Presentations VaultLabs currently lists, dispatched from the UAE. Check the lot against batch verification before ordering.

Semaglutide

semaglutide 30mg

Tirzepatide

tirzepatide 30mg

Semaglutide overview Tirzepatide overview All comparisons